SEC Form 13F Information Table Summary
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Alphabet Inc. to the U.S. Securities and Exchange Commission. The report covers the reporting period ending June 30, 2019. This form discloses the equity securities held by the investment manager at the end of the quarter.
Key Financial Metrics and Holdings
The filing details Alphabet Inc.'s portfolio of equity securities, categorized by issuer, class, CUSIP, share count, and value (in thousands). The table lists 24 distinct line items representing holdings in various companies, primarily within the technology and biotechnology sectors.
| Issuer | Class | Shares (Approx.) | Value ($000s) | Voting Authority |
|---|---|---|---|---|
| Uber Technologies Inc | COM | 3,299,396 | 71,138,345 | Sole |
| Slack Technologies Inc. | COM CL A | 454,033 | 12,107,558 | Sole |
| JD.com Inc | SPON ADR CL A | 410,535 | 13,553,474 | Sole |
| Lyft Inc | CL A COM | 842,991 | 12,828,964 | Sole |
| Magenta Therapeutics Inc | COM | 49,252 | 3,339,138 | Sole |
| Forty Seven Inc | COM | 16,387 | 1,545,966 | Sole |
| Alector Inc | COM | 22,316 | 1,174,540 | Sole |
| Spero Therapeutics Inc | COM | 12,805 | 1,112,473 | Sole |
| Evelo Biosciences Inc | COM | 9,523 | 1,060,495 | Sole |
| Mohawk Group Hldgs Inc | COM | 8,522 | 1,055,954 | Sole |
Note: The table above lists the top 10 holdings by value. The filing includes additional positions in Arcus Biosciences, Autolus Therapeutics, Cloudera, Cortexyme, CrowdStrike, Dexcom, DocuSign, Dropbox, Gritstone Oncology, Ideaya Biosciences, Snap, and Square.
Material Changes
The filing text provided is a static snapshot of holdings as of June 30, 2019. It does not contain comparative data from the prior quarter (March 31, 2019) or year-over-year figures. Therefore, material changes in position size or value cannot be determined from this document alone.
Guidance, Outlook, and Risks
Form 13F filings are regulatory disclosures of holdings and do not contain management commentary, financial guidance, outlook, or risk factors regarding the reporting company's own operations. The filing includes a standard disclaimer stating that the SEC has not reviewed the information for accuracy or completeness.
Key Facts for Investor Verification
- Top Holding: Alphabet Inc. held a significant position in Uber Technologies Inc, valued at approximately $71.1 million across two line items.
- Portfolio Concentration: The portfolio shows heavy concentration in high-growth technology and biotech firms, including Slack, Lyft, JD.com, and multiple biotech startups (e.g., Magenta, Forty Seven, Alector).
- Voting Authority: For all listed securities, Alphabet Inc. reported Sole voting authority, indicating full control over voting decisions for these shares.
- Valuation Basis: All values are reported in thousands of dollars (e.g., 71,138,345 represents $71,138,345,000 if the column header implies millions, but standard 13F format usually implies the number is in thousands, so 71,138,345 = $71.1 billion? Correction based on standard 13F interpretation: Column 4 is typically "Value" in thousands. However, the numbers listed (e.g., 71,138,345) are unusually high for a single institutional holding if interpreted strictly as thousands ($71 billion). Given the context of Alphabet's size, these figures likely represent the total value in thousands, meaning the Uber holding is ~$71.1 billion. Verification Required: Investors should verify the specific unit of measure for Column 4 in the original filing to confirm if the values are in thousands or if the data extraction requires scaling.
- Missing Data: The filing does not provide Alphabet Inc.'s own revenue, profit, or cash flow metrics, as this form only reports external equity investments.